leadf
logo-loader
AIM:NCYT

Novacyt SA

Receive alerts
Market:
AIM
Market Cap:
£509.92 m
Price
722.00 GBX
Change
2.27%
52 weeks high
1276.00
52 weeks low
80.10

In brief

AIM-listed Novacyt operates in the field of cellular diagnostics, with a growing portfolio of cancer and infectious disease products and services. Through its proprietary technology platform Novaprep and a strong international network, Novacyt is able to provide an extensive range of oncology and infectious disease diagnostic products. The group has diversified sales from diagnostic reagents used in oncology, microbiology, haematology and serology markets, and its global customers and partners include major corporates.